# Istituto Oncologico Veneto IRCCS

Source: https://nuclide.cc/institutions/iov-veneto/  
Nuclide record `iov-veneto` (Institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

The Veneto region's OECI-accredited comprehensive cancer centre in Padua, strong in breast cancer trials, melanoma and tumour immunology.

## Summary

Founded in 2005, the Istituto Oncologico Veneto is the IRCCS cancer institute of the Veneto region and coordinates the regional oncology network; it is accredited by the OECI as a comprehensive cancer centre. Pierfranco Conte and Valentina Guarneri's breast oncology group led the ShortHER trial of trastuzumab duration and many neoadjuvant studies, the melanoma unit is a leading Italian immunotherapy trial site, and Vincenzo Bronte's immunology programme is known for myeloid-derived suppressor cells. The institute runs gastrointestinal, thoracic and gynaecological oncology, radiotherapy and nuclear medicine across Padua and Castelfranco Veneto, with a phase 1 unit and the University of Padua's oncology school.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: IOV; Veneto Institute of Oncology
- City: Padua, IT
- Type: cancer-center
- Website: https://www.ioveneto.it

## Sources

- Homepage: https://www.ioveneto.it
- Research: https://www.ioveneto.it/ricerca/

## Connected records

- indications: [HER2-positive breast cancer](https://nuclide.cc/indications/breast-her2-positive/)

---
JSON: https://nuclide.cc/api/v1/entities/iov-veneto.json